Natera Provides Update on Ravgen Trial

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that a jury has reached a verdict in the United States District Court for the Western District of Texas regarding a patent infringement lawsuit brought by Ravgen, Inc. against Natera. Natera noted that the damages award of $57 million was significantly less than the$410 million Ravgen was seeking. In addition, the jury determined there was no willful infringement by Natera. This decision ...